19.08
Schrodinger Inc stock is traded at $19.08, with a volume of 1.01M.
It is down -7.60% in the last 24 hours and up +5.12% over the past month.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
See More
Previous Close:
$20.65
Open:
$20.71
24h Volume:
1.01M
Relative Volume:
0.90
Market Cap:
$1.23B
Revenue:
$193.35M
Net Income/Loss:
$-177.58M
P/E Ratio:
-7.7878
EPS:
-2.45
Net Cash Flow:
$-172.43M
1W Performance:
-7.33%
1M Performance:
+5.12%
6M Performance:
-0.73%
1Y Performance:
+10.10%
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SDGR
Schrodinger Inc
|
19.08 | 1.52B | 193.35M | -177.58M | -172.43M | -2.45 |
![]()
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-30-25 | Initiated | Goldman | Neutral |
Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
Aug-14-25 | Initiated | Barclays | Overweight |
Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
Jul-02-24 | Initiated | Leerink Partners | Outperform |
Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
May-05-23 | Resumed | Piper Sandler | Overweight |
Dec-19-22 | Initiated | Goldman | Neutral |
Mar-01-22 | Initiated | Citigroup | Buy |
Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-19-21 | Initiated | Piper Sandler | Overweight |
Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
Oct-13-21 | Initiated | Berenberg | Buy |
Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
May-25-21 | Initiated | Craig Hallum | Buy |
Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
Mar-02-20 | Initiated | Jefferies | Hold |
Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Sentiment analysis tools applied to Schrödinger Inc.Bull Run & Entry Point Confirmation Alerts - newser.com
Using Bollinger Bands to evaluate Schrödinger Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - newser.com
Why Nordstrom, Inc. stock attracts strong analyst attention - newser.com
Forecasting Schrödinger Inc. price range with options data2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
Is Schrödinger Inc. stock entering bullish territoryJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com
Will Schrödinger Inc. rebound enough to break evenPortfolio Return Summary & High Conviction Investment Ideas - newser.com
Can volume confirm reversal in Schrödinger Inc.Trend Reversal & Stepwise Swing Trade Plans - newser.com
Key metrics from Schrödinger Inc.’s quarterly dataAnalyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
How analysts revise price targets for Schrödinger Inc. (43Z) stockGlobal Markets & Smart Swing Trading Alerts - newser.com
SDGR Sees Price Target Adjustment by Keybanc, Maintains Positive Outlook | SDGR Stock News - GuruFocus
Schrodinger (NASDAQ:SDGR) Price Target Lowered to $28.00 at KeyCorp - MarketBeat
Slow Capital Inc. Purchases New Shares in Schrodinger, Inc. $SDGR - MarketBeat
Will Schrödinger Inc. (43Z) stock benefit from Fed rate cutsJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
Relative strength of Schrödinger Inc. in sector analysisJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
What downside risks could hit Schrödinger Inc. (43Z) stockJuly 2025 Technicals & Safe Entry Trade Reports - newser.com
Can Schrödinger Inc. (43Z) stock sustain breakout momentumJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
How Schrödinger Inc. stock compares to industry benchmarksJuly 2025 News Drivers & Daily Technical Forecast Reports - newser.com
Schrodinger (NASDAQ:SDGR) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Schrodinger (NASDAQ:SDGR) Trading Down 3.6%Here's Why - MarketBeat
Can Schrödinger Inc. (43Z) stock hit consensus price targetsInsider Buying & Weekly Watchlist for Consistent Profits - newser.com
Schrodinger (NASDAQ:SDGR) Stock Rating Upgraded by The Goldman Sachs Group - MarketBeat
Perigon Wealth Management LLC Purchases Shares of 14,636 Schrodinger, Inc. $SDGR - MarketBeat
Goldman Sachs Initiates Coverage of Schrödinger (SDGR) with Neutral Recommendation - Nasdaq
Schrödinger, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Expert Outlook: Schrodinger Through The Eyes Of 5 Analysts - Benzinga
Schrodinger (SDGR) Receives Neutral Rating from Goldman Sachs | SDGR Stock News - GuruFocus
Schrodinger (SDGR) Receives Neutral Rating from Goldman Sachs | - GuruFocus
Goldman Sachs initiates Schrodinger stock with Neutral rating, $19 price target By Investing.com - Investing.com South Africa
Goldman Sachs initiates Schrodinger stock with Neutral rating, $19 price target - Investing.com Nigeria
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Akinsanya Karen | President of R&D, Therapeutics |
Apr 14 '25 |
Sale |
25.09 |
16,723 |
419,570 |
15,625 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):